Raaj Medisafe India Ltd Share Price

Raaj Medisafe
Small Cap | Packaging
₹ No value
Last updated: 05-Dec-2025 ,

Raaj Medisafe India Ltd Live Price Chart

Low: ₹0 High: 0

Raaj Medisafe India Ltd Technicals

Current Price
₹ No value
EMASMA
20 Day ₹ 74.756
50 Day ₹ 78.436
100 Day ₹ 80.842
200 Day ₹ 80.151
20 Day ₹ 75.520
50 Day ₹ 80.180
100 Day ₹ 83.480
200 Day ₹ 85.078

Raaj Medisafe India Ltd Performance

Previous Close ₹
High ₹
Volume 1100
52W Range ₹ 63.56 - ₹ 102.35
Open ₹
Low ₹
Market Cap 95.4 Cr

Raaj Medisafe India Ltd Fundamentals

ROCE 11.407
P/E Ratio 11.680
P/B Ratio 3.080
Industry P/E 3.080
Debt to Equity 23.344
ROE 26.430
EPS 5.820
Dividend Yield 0.000
Book Value 22.076
Face Value 10.000

Raaj Medisafe India Ltd Financials

Particulars Y202503 Y202403 Y202303 Y202203 Y202103
Total Revenue 62.619441 43.309028 38.645354 34.720212 31.825421
Total Expenses 57.364626 39.020058 34.873017 31.045558 29.194363
Profit After Tax 6.131244 3.328532 3.329781 3.012834 2.299436

Raaj Medisafe India Ltd Shareholding Pattern

Promoter Holdings 73.796 %
FIIs 0.000 %
DIIs 0.000 %
MutualFund 0.000 %
Retail 22.899 %
Others - 3.305 %

About Raaj Medisafe India Ltd

History of Raaj Medisafe India Ltd

Raaj Medisafe India Limited, formerly known Manoj Surgical Industries Limited, incorporated in September, 1985, was later on changed from Manoj Surgical Industries Limited to Raaj Medisafe India Limited in July, 2008. The Company is engaged in the business of manufacturing Medical Disposable Devices in Dhar District of Madhya Pradesh. The manufacturing plant at Pithampur is a modern plant conforming to cGMP requirements. The Company's principal activity is to manufacture plastic bottles, caps & plugs, plastic liners and aluminum caps. Pursuant to the order dated 15 October, 2020 passed by the National Company Law Tribunal, Indore Bench at Ahmedabad sanctioning the Scheme of Amalgamation of Padma Polytex India Private Limited with the Company, the Company allotted 58,97,612 Fully paid ...

Similar Stocks

Company 52 Week Market Price P/E Ratio
Cosmo First Ltd ₹ 525.7 - ₹ 1307.2 729.55 19.47
EPL Ltd ₹ 175.28 - ₹ 289.9 201.15 27.75
Garware Hi Tech Films Ltd ₹ 2317.35 - ₹ 5378.1 3657.75 26.72
AGI Greenpac Ltd ₹ 599.1 - ₹ 1307.9 747.05 13.83
Rollatainers Ltd ₹ 1.02 - ₹ 2.65 1.19 -39.33

FAQs on Raaj Medisafe India Ltd

1. Can I buy Raaj Medisafe India Ltd from PL Capital? ›

Yes, you can invest in Raaj Medisafe India Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Raaj Medisafe India Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Raaj Medisafe India Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Raaj Medisafe India Ltd pay dividends? ›

Raaj Medisafe India Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.

3. What is the current share price of Raaj Medisafe India Ltd ? ›

As of 04-12-2025 the share price for Raaj Medisafe India Ltd. is 68 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Raaj Medisafe India Ltd ? ›

The 52-week high and low of Raaj Medisafe India Ltd share price is ₹ 63.56 - ₹ 102.35 as of 04-12-2025 .
PL Ringside View

Our fireside chat series where industry experts and top management share valuable insights for our clients

Youtube

Mark Mobius on India’s Growth, Global Markets, and Investment Opportunities

Youtube

₹100 cr net profit in 7-12 months | Anjali Nashier, Revolt Motors

Youtube

India's Path to Energy Security | Dr. Praveer Sinha, MD & CEO, Tata Power

  • PL Capital Logo

  • Regd. Office : 3rd Floor, Sadhana House,
    570, P. B. Marg, Behind Mahindra Tower,
    Worli, Mumbai - 400 018, India

    View on Google Maps

  • Tel. : 02266322222

    Call us

Prabhudas Lilladher Private Limited | CIN: U67190MH1983PTC029670 | Registered Office Address: 3rd Floor, Sadhana House, 570, P.B. Marg, Worli, Mumbai – 400018, Maharashtra, India | SEBI Registration Details: Stock Broking: INZ000196637 [Membership Codes: NSE – 05977; BSE – 564; MCX – 40690] | Depository Participant: IN-DP-439-2019 [DP Codes: CDSL – 12011300; NSDL – IN303868 | Portfolio Management: INP000009001| Research Analyst: INZ000000271 | Investment Advisors: INA000018267 [BSEASL Membership Code: BASL2042] | AMFI ARN: 3276 | Compliance Officer: Mrs. Snehal Kathrani; Tel: 02266322420; email: co@plindia.com | For any Grievance/ Dispute: Stock Broking; email: grievance-br@plindia.com; Tel: 02266322366; Depository Participant; email: grievance-dp@plindia.com; Tel: 02266322452; Portfolio Management; email: grievance-pms@plindia.com; Tel: 02266322350.

To register your grievance on SCORES log onto: https://scores.gov.in/scores/Welcome.html. Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, Email ID

To register your grievance on Smart ODR Portal log onto: Online Dispute Resolution Portal (ODR Portal).

Standard Disclaimers: (a) Investment in securities market are subject to market risks, read all the related documents carefully before investing. (b) Brokerage will not exceed the SEBI prescribed limits. (c) Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The brand name and Logo ‘PL Capital’ are the registered trademarks of Prabhudas Lilladher Advisory Services Private Limited which is the holding company of Prabhudas Lilladher Group of Companies .

Prabhudas Lilladher Private Limited is not associated with any unregulated platform which claims performance/return for algorithmic strategy for trading. Trading with unregulated platforms for algorithmic strategy shall be at your own risk and Prabhudas Lilladher Private Limited or its affiliates shall not be liable for the same.

Risk Disclosure on Derivatives: (a) 9 out of 10 individual traders in equity futures and options segment, incurred net losses. (b) On an average, loss makers registered net trading loss close to ₹ 50,000 (c) Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs. (d) Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source